Literature DB >> 21411147

Fulminant myocarditis associated with novel H1N1 influenza A.

Rami N Khouzam1, Constantin Parizianu, Abdul Moiz Hafiz, Shalinee Chawla, Richard Schwartz.   

Abstract

Myocarditis secondary to H1N1 influenza has been described in children, but only very rarely in adults. We describe a 36-year-old man with no significant medical history who presented with flu-like symptoms of 3-week duration. When he sought medical attention, he was already manifesting heart failure secondary to fulminant myocarditis, along with multiorgan failure. Despite aggressive management, including circulatory support with a catheter-based mechanical cardiac assist device (Impella 2.5 Cardiac Assist Device, Abiomed, Danvers, MA) as a bridge to cardiac transplant, and aggressive antiviral and antibacterial therapy, the patient died of cardiac arrest. An H1N1 polymerase chain reaction postmortem assay produced positive results, and a diagnosis of fulminant viral myocarditis and multiorgan system failure was established.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21411147     DOI: 10.1016/j.hrtlng.2011.01.004

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  11 in total

1.  Atypical clinic presentation of pandemic influenza A successfully rescued by extracorporeal membrane oxygenation - Our experience and review of the literature.

Authors:  Massimo Bonacchi; Marco Ciapetti; Gabriella Di Lascio; Guy Harmelin; Guido Sani; Adriano Peris
Journal:  Interv Med Appl Sci       Date:  2013-12-20

Review 2.  Management of fulminant myocarditis: a diagnosis in search of its etiology but with therapeutic options.

Authors:  Bernhard Maisch; Volker Ruppert; Sabine Pankuweit
Journal:  Curr Heart Fail Rep       Date:  2014-06

Review 3.  Cardiovascular Complications in Major 21st Century Viral Epidemics and Pandemics: an Insight into COVID-19.

Authors:  Muzna Hussain; Patrick Collier; Rohit Moudgil
Journal:  Curr Cardiol Rev       Date:  2021

4.  Successful treatment of novel H1N1 influenza related fulminant myocarditis with extracorporeal life support.

Authors:  Prashant Nanasaheb Mohite; Aron Frederik Popov; Armin Bartsch; Bartlomiej Zych; Dhruva Dhar; Ajay Moza; Heike Krueger; André Ruediger Simon
Journal:  J Cardiothorac Surg       Date:  2011-12-20       Impact factor: 1.637

Review 5.  The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection.

Authors:  Subhashini A Sellers; Robert S Hagan; Frederick G Hayden; William A Fischer
Journal:  Influenza Other Respir Viruses       Date:  2017-09       Impact factor: 4.380

Review 6.  Influenza Myopericarditis and Pericarditis: A Literature Review.

Authors:  Milan Radovanovic; Marija Petrovic; Michel K Barsoum; Charles W Nordstrom; Andrew D Calvin; Igor Dumic; Dorde Jevtic; Richard D Hanna
Journal:  J Clin Med       Date:  2022-07-15       Impact factor: 4.964

7.  Predominance of HA-222D/G polymorphism in influenza A(H1N1)pdm09 viruses associated with fatal and severe outcomes recently circulating in Germany.

Authors:  Marianne Wedde; Stephanie Wählisch; Thorsten Wolff; Brunhilde Schweiger
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

8.  Unchanged severity of influenza A(H1N1)pdm09 infection in children during first postpandemic season.

Authors:  Mathias Altmann; Lena Fiebig; Silke Buda; Rüdiger von Kries; Manuel Dehnert; Walter Haas
Journal:  Emerg Infect Dis       Date:  2012-11       Impact factor: 6.883

9.  Myocarditis Associated with Influenza A H1N1pdm2009.

Authors:  Akira Ukimura; Hidetoshi Satomi; Yukimasa Ooi; Yumiko Kanzaki
Journal:  Influenza Res Treat       Date:  2012-12-17

Review 10.  Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection.

Authors:  Radha Gopal; Michael A Marinelli; John F Alcorn
Journal:  Front Immunol       Date:  2020-10-22       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.